Pharma Stock Roundup: FDA Approvals for LLY, MRK, AZN & JNJ Drugs
FDA approves Lilly's eczema drug, Ebglyss, and the expanded use of Novartis' Kisqali, Merck's Keytruda and AstraZeneca's Fasenra.
MM&M23h
Rx Rundown: MaxCyte, Roche, and more
Kajeet and Avery Telehealth announced a strategic partnership. The FDA has approved Apple’s sleep apnea detection feature.
Mena FN23h
How Critical Demand For Metastatic Breast Cancer Therapies Is Producing A Multi-Billion Dollar Opportunity For Biotechs - Financial News Media
Read these full press releases and more news for ONCY at: Other recent cancer developments in the biotech industry of note include: Novartis AG (NYSE: NVS) recently announced that the US Food and Drug ...
BlackDoctor19h
A 10-Year Trial Found a Diet to Help Prevent Alzheimer’s in Black Americans
A study shows the MIND diet had a stronger predictive effect on cognitive decline in Black trial participants compared to ...
BioPharma Dive9h
Novo sinks on obesity drug results; Sanofi reveals anticipated MS data
A pill Novo acquired produced modest weight loss but raised safety questions. Elsewhere, Sanofi detailed the silver lining it found in a recent study and a heart drug developer’s shares surged.
Indiatimes16h
Novartis India Share Price
Novartis India Ltd., incorporated in the year 1947, is a Small Cap company (having a market cap of Rs 2,650.43 Crore) operating in Pharmaceuticals sector. Novartis India Ltd. key Products/Revenue ...
Hindustan Times18h
India News
A shortlist of the biggest headlines, recommended stories, and a special collection of news items that you should check out.